Creation of New Businesses through the Integration of NVC, Biology and Electronics
First written in FY2018. 2 of 6 entries say "Advanced", first in FY2019. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026ReframedAnnual report
「The Company established the Sustainability Promotion Office, which advances a Group-wide sustainability strategy; the Future Co-Creation Office, which handles new development in areas such as healthcare and energy, as well as advanced technologies including blockchain and MI that can be used across the Company; and Nagase Future Investments株式会社, which invests in startups from a perspective different from that of existing businesses and aims to create next-generation businesses.」
The former NVC-led new-business creation activities were expanded to include the Future Co-Creation Office, CVC operations, and business incubation in healthcare, energy, and data-related fields. - FY2023RestatedAnnual report
「Development is being advanced in areas including the SaaS-based materials informatics support service “TABRASA”; the “Axonerve” IP core, which accelerates low latency and processing performance in 5G network infrastructure; non-von Neumann hardware AI; five-sense sensing technologies; a blockchain-based trading support system; and a medical imaging platform.」
NVC has continued developing new businesses involving AI, materials informatics, next-generation communications, and other areas. - FY2022RestatedAnnual report
「Development is being advanced in areas including the SaaS-based materials informatics support service “TABRASA”; the “Axonerve” IP core, which accelerates low latency and processing performance in 5G network infrastructure; portable sensors based on the five human senses; a blockchain-based trading support system; elemental technologies for next-generation AI hardware; and AI-based disease prevention technologies.」
Development of TABRASA, Axonerve, and other initiatives has continued as part of NVC's new-business creation themes. - FY2021AdvancedAnnual report
「In the materials informatics field, the service launch of the new-materials discovery platform “TABRASA” began.」
NVC's new-business creation theme advanced to the commercialisation stage with the launch of the TABRASA new-materials discovery platform for materials informatics. - FY2019AdvancedAnnual report
「The NVC (New Value Creation) Office aims to drive innovation across the Group and create new value by anticipating trends such as AI and IoT, thereby developing business pillars not previously present in the Group. It conducts development activities in materials informatics, a technology field for new materials development that combines advanced data-processing technologies with materials science, as well as in solutions enabling server acceleration to balance the latency requirements and processing performance expected of edge servers following the implementation of next-generation communications standards, while reducing system power consumption. The office belongs to the Corporate-wide segment.」
The research themes have been made more specific, shifting from the former biotechnology-electronics integration theme to materials informatics, edge servers, and server acceleration. - FY2018First statedAnnual report
「The NVC (New Value Creation) Office was established in April 2017 to drive innovation and create new value, with the aim of developing future business pillars for the Group. Through the Research Frontiers Institute (RFI) consortium with IBM, it conducts development activities under the theme of Bio-Inspired Technology, which focuses on combining biotechnology and electronics. These activities include contributing to the development of AI-based information search systems (Accelerated Material Discovery) and ultra-low-power devices (neuromorphic devices), as well as developing products applying biomimicry.」
Established in April 2017, the NVC Office is pursuing the creation of new businesses combining biotechnology and electronics, including AI, neuromorphic devices, and biomimicry, through research consortia with IBM and others.